Antengene Announces XPOVIO® plus Bortezomib and Dexamethasone Included for Reimbursement by the PBS in Australia for the Treatment of Relapsed and/or Refractory Multiple Myeloma
PR Newswire Asia
- XPOVIO^® (selinexor) is *the first and only *selective inhibitor of nuclear export (SINE) inhibitor approved by the..